You
David Israeli, CEO | Ehud Schwammenthal | Yosi TuvalUs
Zeev BinmanFacts:
- Founded in 2012
- Partnered in 2012
The Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) is a self-expanding, percutaneous heart pump, intended to provide temporary mechanical circulatory support for the left ventricle (LV) during high-risk percutaneous coronary interventions (HR-PCI) and in patients admitted with cardiogenic shock (CS).
The Elevate™ Pump is delivered sheathed into the LV through various commercial 10 Fr femoral introducer sheaths, fully over-the-wire (0.018”). Once in the LV, the self-expanding pump is un-sheathed, expanding from 9 Fr to 30 Fr.
The Elevate™ System was successfully evaluated in First-in-Human and US Early Feasibility Study (EFS) studies of HR-PCI patients. A US HR-PCI Pivotal Study against Impella is commencing in 2025.
